Dr. Martens meets guidance, plans to focus on U.S. market for growth in FY'26.

From Investing.com: 2024-05-30 15:23:55

Dr. Martens’ FY’24 results met guidance, but U.S. performance was disappointing. The company plans to focus on the U.S. market with targeted marketing and cost-saving initiatives in FY’25 to return to growth in FY’26. New CFO Giles Wilson sees growth opportunities in existing and untapped markets despite revenue and profit declines.



Read more at Investing.com: Dr. Martens maintains steady course despite U.S. headwinds By Investing.com